| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $12,500,000 | 1 | 100 |
Sells | $0 | 0 | 0 |
| AI Biotechnology LLC | 10 percent owner | 1 | $12.5M | 0 | $0 | $12.5M |
Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its key product candidates include ZB-168, an anti-IL7Rα inhibitor engineered to address conditions influenced by the IL7 and TSLP biological pathways. The company is also advancing Torudokimab, a monoclonal antibody that neutralizes IL-33, which is currently in Phase 2 clinical development.
Over the last 12 months, insiders at Zura Bio Limited have bought $12.5M and sold $0 worth of Zura Bio Limited stock.
On average, over the past 5 years, insiders at Zura Bio Limited have bought $8.62M and sold $6.6M worth of stock each year.
Highest buying activity among insiders over the last 12 months: AI Biotechnology LLC (10 percent owner) — $12.5M.
The last purchase of 2,000,000 shares for transaction amount of $12.5M was made by AI Biotechnology LLC (10 percent owner) on 2026‑02‑26.
| 2026-02-26 | AI Biotechnology LLC | 10 percent owner | 2M 2.8396% | $6.25 | $12.5M | -21.86% | ||
| 2024-11-25 | Sale | Thiara Parvinder | director | 1M 1.3731% | $2.73 | $2.73M | -45.75% | |
| 2024-09-11 | Sale | Thiara Parvinder | director | 3.8M 5.152% | $2.70 | $10.26M | -52.57% | |
| 2024-09-04 | Sale | Sidhu Someit | director | 51,728 0.1005% | $3.87 | $200,187 | -57.97% | |
| 2024-05-17 | Ploos van Amstel Arnout | director | 80,000 0.2491% | $6.20 | $496,000 | -46.28% | ||
| 2024-04-22 | Sidhu Someit | director | 1.19M 1.8655% | $3.13 | $3.72M | +5.44% | ||
| 2024-04-22 | Munshi Amit | director | 159,744 0.2511% | $3.13 | $499,999 | +5.44% | ||
| 2024-04-22 | Howell Michael | See Remarks | 7,987 0.0126% | $3.13 | $24,999 | +5.44% | ||
| 2024-04-22 | Nistala Kiran | Executive Vice President | 3,195 0.005% | $3.13 | $10,000 | +5.44% |
| AI Biotechnology LLC | 10 percent owner | 6552725 6.8027% | $26.15M | 1 | 0 | |
| Sidhu Someit | director | 2085418 2.165% | $8.32M | 1 | 1 | +5.44% |
| Munshi Amit | director | 777384 0.807% | $3.1M | 1 | 0 | +5.44% |
| Ploos van Amstel Arnout | director | 100000 0.1038% | $399,000.00 | 1 | 0 | <0.0001% |
| Howell Michael | See Remarks | 7987 0.0083% | $31,868.13 | 1 | 0 | +5.44% |
| Nistala Kiran | Executive Vice President | 3195 0.0033% | $12,748.05 | 1 | 0 | +5.44% |
$31,123,523 | 108 | 6.46% | $387.86M | |
$24,384,691 | 42 | -30.27% | $396.82M | |
$22,020,194 | 25 | 38.25% | $405.58M | |
$112,238,340 | 19 | 39.16% | $421.48M | |
$2,471,510 | 19 | 17.33% | $334.18M |
| Increased Positions | 48 | +60.76% | 9M | +21.03% |
| Decreased Positions | 35 | -44.3% | 7M | -18.01% |
| New Positions | 22 | New | 3M | New |
| Sold Out Positions | 15 | Sold Out | 4M | Sold Out |
| Total Postitions | 92 | +16.46% | 42M | +3.03% |
| Suvretta Capital Management, Llc | $30,375.00 | 8.42% | 5.47M | +611,952 | +12.59% | 2025-09-30 |
| Vr Adviser, Llc | $25,703.00 | 7.13% | 4.63M | 0 | 0% | 2025-09-30 |
| Jpmorgan Chase & Co | $25,664.00 | 7.11% | 4.62M | -35,752 | -0.77% | 2025-09-30 |
| Great Point Partners I Lp | $21,178.00 | 5.87% | 3.82M | +645,736 | +20.37% | 2025-09-30 |
| Adage Capital Partners Gp, L.L.C. | $16,902.00 | 4.68% | 3.05M | +3M | New | 2025-09-30 |
| Braidwell Lp | $13,724.00 | 3.8% | 2.47M | 0 | 0% | 2025-09-30 |
| Ikarian Capital, Llc | $11,834.00 | 3.28% | 2.13M | +2M | New | 2025-09-30 |
| Armistice Capital, Llc | $8,658.00 | 2.4% | 1.56M | +24,000 | +1.56% | 2025-09-30 |
| Affinity Asset Advisors, Llc | $7,073.00 | 1.96% | 1.27M | +1M | +470.6% | 2025-09-30 |
| Boothbay Fund Management, Llc | $4,574.00 | 1.27% | 824,078 | +824,078 | New | 2025-09-30 |